Convenient PET-tracer production via SuFEx F-fluorination of nanomolar precursor amounts.

Nils Walter, Jan Bertram, Birte Drewes, Victor Bahutski, Marco Timmer, Markus B Schütz, Felicia Krämer, Felix Neumaier, Heike Endepols, Bernd Neumaier, Boris D Zlatopolskiy

Journal: European journal of medicinal chemistry 2022;237():114383

PMID: 35447431

Abstract

Recently, a protocol for radiolabeling of aryl fluorosulfates ("SuFEx click radiolabeling") using ultrafast F/F isotopic exchange has been reported. Although promising, the original procedure turned out to be rather inefficient. However, systematic optimization of the reaction parameters allowed for development of a robust method for SuFEx radiolabeling which obviates the need for azeotropic drying, base addition and HPLC purification. The developed protocol enabled efficient F-fluorination of low nanomolar amounts of aryl fluorosulfates in highly diluted solution (micromolar concentrations). It was successfully used to prepare a series of 29 F-fluorosulfurylated phenols - including modified ezetimibe, α-tocopherol and etoposide, the two tyrosine derivatives Boc-Tyr([F]FS)-OMe and H-Tyr([F]FS)-OMe, the FAP-specific ligand [F]FS-UAMC1110, and the DPA-714 analog [F]FS-DPA - in fair to excellent yields. Preliminary evaluation demonstrated sufficient in vivo stability of radiofluorinated electron rich or neutral {Boc-Tyr([F]FS)-OMe), H-Tyr([F]FS)-OMe and [F]FS-DPA} aryl fluorosulfates. Furthermore, [F]FS-DPA was identified as a promising tracer for visualization of TSPO expression.

Copyright © 2022 Elsevier Masson SAS. All rights reserved.

Address: Forschungszentrum Jülich GmbH, Institute of Neuroscience and Medicine, Nuclear Chemistry (INM-5), Wilhelm-Johnen-Straße, 52425, Jülich, Germany. Electronic address: [email protected].; Forschungszentrum Jülich GmbH, Institute of Neuroscience and Medicine, Nuclear Chemistry (INM-5), Wilhelm-Johnen-Straße, 52425, Jülich, Germany. Electronic address: [email protected].; Forschungszentrum Jülich GmbH, Institute of Neuroscience and Medicine, Nuclear Chemistry (INM-5), Wilhelm-Johnen-Straße, 52425, Jülich, Germany. Electronic address: [email protected].; Forschungszentrum Jülich GmbH, Institute of Neuroscience and Medicine, Nuclear Chemistry (INM-5), Wilhelm-Johnen-Straße, 52425, Jülich, Germany. Electronic address: [email protected].; University of Cologne, Faculty of Medicine and Cologne University Hospital, Center for Neurosurgery, Kerpener Straße 62, 50937, Cologne, Germany. Electronic address: [email protected].; University of Cologne, Faculty of Medicine and Cologne University Hospital, Institute of Diagnostic and Interventional Radiology, Kerpener Straße 62, 50937, Cologne, Germany. Electronic address: [email protected].; University of Cologne, Faculty of Medicine and Cologne University Hospital, Institute of Radiochemistry and Experimental Molecular Imaging, Kerpener Straße 62, 50937, Cologne, Germany. Electronic address: [email protected].; Forschungszentrum Jülich GmbH, Institute of Neuroscience and Medicine, Nuclear Chemistry (INM-5), Wilhelm-Johnen-Straße, 52425, Jülich, Germany; University of Cologne, Faculty of Medicine and Cologne University Hospital, Institute of Radiochemistry and Experimental Molecular Imaging, Kerpener Straße 62, 50937, Cologne, Germany. Electronic address: [email protected].; Forschungszentrum Jülich GmbH, Institute of Neuroscience and Medicine, Nuclear Chemistry (INM-5), Wilhelm-Johnen-Straße, 52425, Jülich, Germany; University of Cologne, Faculty of Medicine and Cologne University Hospital, Institute of Radiochemistry and Experimental Molecular Imaging, Kerpener Straße 62, 50937, Cologne, Germany; University of Cologne, Faculty of Medicine and Cologne University Hospital, Department of Nuclear Medicine, Kerpener Straße 62, 50937, Cologne, Germany. Electronic address: [email protected].; Forschungszentrum Jülich GmbH, Institute of Neuroscience and Medicine, Nuclear Chemistry (INM-5), Wilhelm-Johnen-Straße, 52425, Jülich, Germany; University of Cologne, Faculty of Medicine and Cologne University Hospital, Institute of Radiochemistry and Experimental Molecular Imaging, Kerpener Straße 62, 50937, Cologne, Germany; Max Planck Institute for Metabolism Research, Gleueler Straße 50, 50931, Cologne, Germany. Electronic address: [email protected].; Forschungszentrum Jülich GmbH, Institute of Neuroscience and Medicine, Nuclear Chemistry (INM-5), Wilhelm-Johnen-Straße, 52425, Jülich, Germany; University of Cologne, Faculty of Medicine and Cologne University Hospital, Institute of Radiochemistry and Experimental Molecular Imaging, Kerpener Straße 62, 50937, Cologne, Germany; Max Planck Institute for Metabolism Research, Gleueler Straße 50, 50931, Cologne, Germany. Electronic address: [email protected].

Link outs

Subscription / membership required

Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.